Vivimed Labs Limited is an India-based company engaged in the manufacture of Active Pharmaceutical ingredients (API’s), Intermediates and Nutraceutical ingredients with predominance in exports. The Company is primarily engaged in Pharma segment. In addition to generic business, the Company, through its custom synthesis business, supports innovator pharma companies for their patented products business right from gram scale requirements for clinical trials to launch as well as late life cycle management. Its manufacturing facilities are equipped to deliver a range of dosage delivery formats that include capsules, tablets, syrups & liquids, sprays & ointments.As of 26 May 2026, VIVIMED LABS LIMITED share price is ₹6.40. The stock opened at ₹6.53, compared to its previous close of ₹6.54. During today's trading session, VIVIMED LABS LIMITED share price moved in the range of ₹6.36 to ₹6.65, with an average price of ₹6.51 for the day. Looking at its last 52-week, the stock has touched a low of ₹6.36 and a high of ₹6.65. On the performance front, VIVIMED LABS LIMITED share price has declined by 75.79% over the last six months and is down 75.79% on a year-on-year basis.
The market capitalization of VIVIMED LABS LIMITED is ₹54 Crs, with a P/E ratio of -1.5 and a dividend yield of 0.00%.